OPAT

Infectious Disease Connect Expands Telemedicine Services

Retrieved on: 
Martedì, Aprile 16, 2024
Telehealth, Hospital, OPAT, Infection, Entrepreneurship, Nursing, Patient, Physician, Health, ID, Pharmacist

PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet growing demand.

Key Points: 
  • PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet growing demand.
  • The company now offers two cutting-edge service lines — pediatric infectious diseases telemedicine (tele-ID) and tele-Outpatient Parenteral Antimicrobial Therapy (tele-OPAT).
  • Addressing the problem of access to pediatric infectious diseases care, ID Connect's pediatric tele-ID service provides right-sized, top-quality pediatric ID care to hospitals and health systems via telemedicine.
  • Without our services, one hospital would have resorted to transferring approximately 30% of their pediatric infectious diseases cases.

Kern Medical Chooses PrecisePK to Provide Bayesian Precision Dosing Solutions

Retrieved on: 
Giovedì, Maggio 25, 2023
BCPS, Society, Infectious Diseases Society of America, MIC, Doctor of Pharmacy, Partnership, Kern Medical Center, Staphylococcus, OPAT, Education, Workflow, Society of Infectious Diseases Pharmacists, Infection, ID, Pharmacist, Vancomycin, Patient, SAN, Microsoft Excel, AUC, Knowledge, UCLA, American Society of Health-System Pharmacists, Pharmaceutical industry, List of things named after Thomas Bayes

SAN DIEGO, May 25, 2023 /PRNewswire/ -- Today, PrecisePK welcomes Kern Medical as its latest institution to implement innovations in precision dosing for vancomycin and other antibiotics using the Bayesian AUC-based method.

Key Points: 
  • SAN DIEGO, May 25, 2023 /PRNewswire/ -- Today, PrecisePK welcomes Kern Medical as its latest institution to implement innovations in precision dosing for vancomycin and other antibiotics using the Bayesian AUC-based method.
  • This recent alliance with Kern Medical adds to the system-wide endeavor of accomplishing personalized and precision dosing with a modernized approach by leveraging technology.
  • Kern Medical's vancomycin dosing workflow is standardized and improved by PrecisePK's Bayesian precision dosing tools.
  • With Bayesian precision dosing, it's more than the right dose for the right patient at the right time.

Healix and InsightRX Provide Patient-Specific Precision Dosing for Outpatient Infusion Therapy

Retrieved on: 
Martedì, Agosto 9, 2022
Machine learning, OPAT, Risk, Patient safety, Precision medicine, CEO, Population, Infection, Acute kidney injury, Skin, Blood, Health, Compliance, Allergy, Patient, SAN, Neurology, Partnership, Doctor of Philosophy, MRSA, Research, Physician, Rheumatology, Gastroenterology, Entrepreneurship, Pharmaceutical industry, Medical device, Country, Reiki

SAN FRANCISCO, Aug. 9, 2022 /PRNewswire/ -- Today InsightRX, a high-growth healthcare technology company that provides cloud-based clinical decision support for point-of-care precision dosing, announced its partnership with Healix, the national leader in physician office-based infusion services. InsightRX uses patient-specific data, pharmacokinetic/ pharmacodynamic (PK/PD) models, and Bayesian forecasting to deliver precision dosing guidance based on each patient's unique pharmacological profile.

Key Points: 
  • InsightRX uses patient-specific data, pharmacokinetic/ pharmacodynamic(PK/PD) models, and Bayesian forecasting to deliver precision dosing guidance based on each patient's unique pharmacological profile.
  • InsightRX Nova, the company's clinical decision support tool for prospective dosing, guides physicians in determining the optimal initial dose for each patient.
  • The InsightRX precision dosing platform now supports more than 2,000 physicians and 300 infusion clinics across the country, and is available across the entire Healix enterprise.
  • Since implementing InsightRX Nova in April 2021, Healix sites have seen low rates of acute kidney injury, ensuring patient safety.

Global $8.14 Bn Infusion Pumps & Accessories Market 2022-2030 by Type, Application, and End User - ResearchAndMarkets.com

Retrieved on: 
Lunedì, Maggio 9, 2022
Medical Devices, Health, COVID-19, OPAT, Degenerative disease, Baxter International, Gastroenterology, Pump, Texas Homecare, Medtronic, EVP, Mindray, Prevalence, Patient, EDS, Cancer, Incidence, Diabetes, Hospital, Conditional sentence, Adoption, IV, CAGR, Pediatrics, Technology, Needle, Growth, Medical device, Medicine, Video game

The "Infusion Pumps & Accessories Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Infusion Pumps & Accessories Market by Type, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021--2030" report has been added to ResearchAndMarkets.com's offering.
  • The factors that drive the growth of the infusion pumps & accessories market include increase in prevalence of chemotherapy procedures and rise in demand of infusion pumps for pediatric use.
  • The infusion pumps & accessories market is segmented on the basis of type, application, end user, and region.
  • Furthermore, the devices & pumps is divided into syringe infusion pumps, insulin infusion pumps, volumetric infusion pumps, ambulatory infusion pumps, patient controlled analgesia pumps, implantable infusion pumps and enteral infusion pumps.